The cutting edge science and research at the Healey Center is producing results from innovative therapies and ground breaking drug trials.
Researchers are working on identifying the specific biological pathways in cells involved in muscle and nerve function that are lost in the presence of ALS and they are working on strategies to repair them.
The HEALEY ALS Platform Trial serves as an efficient and effective tool to accomplish the goal of repairing damaged cells and prevent ALS from occurring entirely. We are currently entering Phase 3 of the trial and showing great success.
HEALEY & AMG center scientists are pioneering a novel approach to nerve transplants (replacing a damaged nerve with a healthy nerve from a nearby muscle to restore strength) using motor neurons from non-embryonic human stem cells. These stem cells hold great promise in ALS because of the muscle degeneration implication in ALS.
The center is collaborating with many different companies for therapy including Ionis Pharmaceuticals for a Gene Therapy treatment.
